Multicenter evaluation of the QIAstat-Dx Gastrointestinal Panel 2, a multiplex PCR platform for the diagnosis of acute gastroenteritis
Journal of Clinical Microbiology · 13.08.2025 · 63 (8)
DOI: 10.1128/jcm.01983-24 ↗Kurz gefasst
Multizentrische Studie in der Zeitschrift Journal of Clinical Microbiology, erschienen am 13.08.2025. Verfasst von Wendy A Szymczak und 23 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pathology, Albert Einstein College of Medicine and Montefiore Medical Center, Bronx, New York, USA. Hauptthemen laut MEDLINE: Gastroenteritis, Molecular Diagnostic Techniques, Multiplex Polymerase Chain Reaction. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 41 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
The QIAstat-Dx Gastrointestinal Panel 2 (GI2 Panel) is a sample-to-answer multiplex PCR instrument that can detect 17 targets in a run time of about 80 minutes. The performance of the QIAstat-Dx GI2 Panel was evaluated by testing 1,939 prospective, 119 prospectively collected and then archived positive clinical samples and 750 retrospective clinical specimens across 13 sites in Europe and the United States. Specimens tested included bulk stool samples preserved in modified Cary-Blair transport medium. For most targets, results were compared to those of the FilmArray GI panel (13/17), and discordant results were adjudicated with a third assay. For the remaining targets (4/17), a composite comparator method was used, which included three comparator assays for each target. Before discordant resolution, the QIAstat-Dx GI2 Panel positive percent agreement (PPA) was 95% or greater for 5/17 targets ( Campylobacter , E. coli O157, Cryptosporidium, Cyclospora cayetanensis, and Giardia lamblia ) and 90% or greater for 11/17 targets: adenovirus F40/F41, astrovirus, norovirus GI/GII, rotavirus A, Plesiomonas shigelloides , enteropathogenic Escherichia coli , enterotoxigenic E. coli , Salmonella , Yersinia enterocolitica, Shiga-like toxin E. coli (STEC) stx1/stx2 , and Shigella /enteroinvasive E. coli . No cases of Entamoeba histolytica were encountered during the clinical study. The negative percent agreement (NPA) was >98.9% for all QIAstat-Dx GI2 Panel targets. The three most common pathogens identified in single and co-infections were enteropathogenic E. coli (9.9%), Campylobacter (5.2%), and norovirus GI/GII (3.1%). In summary, this clinical study examined more than 2,800 samples from Europe and the U.S. using the QIAstat-Dx GI2 Panel and identified 90%–100% PPA and 99% NPA for its 17 targets. IMPORTANCE The manuscript highlights the significance and impact of the QIAstat-Dx GI2 Panel, a sample-to-answer multiplex PCR instrument capable of detecting 17 targets in approximately 80 minutes. This comprehensive clinical study, conducted across 13 sites in Europe and the United States, evaluated the performance of the panel using over 2,800 clinical samples. The results demonstrate a high accuracy of the QIAstat-Dx GI2 panel, with a PPA equal to or higher than 90% for all targets and an NPA greater than 98.9% for all targets. These findings underscore the reliability and effectiveness of the GI2 panel in the rapid and precise detection of gastrointestinal pathogens, which is crucial for timely diagnosis and treatment of infections.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Pathology, Albert Einstein College of Medicine and Montefiore Medical Center, Bronx, New York, USA.
- Copenhagen University Hospital and Hvidovre, Copenhagen, Denmark.
- Department of Clinical Microbiology, Hospital Universitari Vall d'Hebron, Barcelona, Spain.
- CIBER de Enfermedades Infecciosas (CIBERINFEC), Instituto de Salud Carlos III, Madrid, Community of Madrid, Spain.
- Department of Genetics and Microbiology, Universitat Autònoma de Barcelona, Bellaterra, Spain.
- Laboratory Alliance of Central, Liverpool, New York, USA.
ORCID-Profile: Wendy A Szymczak, Paul Granato, Donna M Wolk, Daniel D Rhoads, Yvan Caspar, Romney Humphries, Ester Sala, Martí Juanola-Falgarona
Zitieren
APA
Szymczak, W. A., Engsbro, A. L., Lisby, J. G., González-López, J. J., Granato, P., Ledeboer, N., Wolk, D. M., Young, S., Rhoads, D. D., Caspar, Y., Steed, L., Humphries, R., Bielefeldt, C., Hermanowski, M., de Diego, J. L., Leibhan, H., Boher, P., Camprubí, C., Orthodoxou, M., …, & Bialas, J. (2025). Multicenter evaluation of the QIAstat-Dx Gastrointestinal Panel 2, a multiplex PCR platform for the diagnosis of acute gastroenteritis. Journal of Clinical Microbiology, 63(8). https://doi.org/10.1128/jcm.01983-24
Vancouver
Szymczak WA, Engsbro AL, Lisby JG, González-López JJ, Granato P, Ledeboer N, et al. Multicenter evaluation of the QIAstat-Dx Gastrointestinal Panel 2, a multiplex PCR platform for the diagnosis of acute gastroenteritis. Journal of Clinical Microbiology. 2025;63(8). doi:10.1128/jcm.01983-24
BibTeX
@article{Szymczak2025,
author = {Szymczak, Wendy A and Engsbro, Anne Line and Lisby, Jan Gorm and González-López, Juan José and Granato, Paul and Ledeboer, Nathan and Wolk, Donna M and Young, Stephen and Rhoads, Daniel D and Caspar, Yvan and Steed, Lisa and Humphries, Romney and Bielefeldt, Christopher and Hermanowski, Markus and de Diego, Juana L and Leibhan, Hendrik and Boher, Pau and Camprubí, Carla and Orthodoxou, Maria and Sala, Ester and Johnson, Sarah and Juanola-Falgarona, Martí and Manissero, Davide and Bialas, Johanna},
title = {Multicenter evaluation of the QIAstat-Dx Gastrointestinal Panel 2, a multiplex PCR platform for the diagnosis of acute gastroenteritis},
journal = {Journal of Clinical Microbiology},
year = {2025},
volume = {63},
number = {8},
doi = {10.1128/jcm.01983-24}
}
EUVIMED